Skip to main content
Book cover

Handbook of Quality of Life in Cancer pp 251–264Cite as

Quality of Life and Cancer-Related Fatigue: Prevalence, Assessment and Interventions

Abstract

Cancer-related fatigue (CrF) is the most common symptom in cancer patients with prevalence rate between 59% and 100%. CrF is an unusual feeling of exhaustion, weakness or a loss of activity due to cancer diagnosis or treatment and is described as a multidimensional construct including physical, cognitive and emotional dimensions. Although there have been a lot of research activities, there is no clear pathogenetic model to explain how the multicausal factors of CrF are interacting. Screening and assessment measures have been developed to identify the level of CrF in clinical routine or clinical trials. As in most cases the causes of CrF are not well known, the treatment approaches are primarily aimed to help the patient cope with the symptoms of CrF and the distress due to CrF. The treatment options include non-pharmacological interventions, for example, physical activity and exercise, psychosocial and mind-body interventions and pharmacological interventions.

Keywords

  • Cancer-related fatigue, Cancer, Assessment, Depression, Quality of life, Psychosocial interventions, Pharmacological interventions

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-030-84702-9_16
  • Chapter length: 14 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   169.00
Price excludes VAT (USA)
  • ISBN: 978-3-030-84702-9
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   219.99
Price excludes VAT (USA)
Learn about institutional subscriptions
Fig. 16.1
Fig. 16.2

References

  1. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer. 2004;91:822–8.

    Google Scholar 

  2. Henry DH, Viswanathan HN, Elkin EP, et al. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional survey in the U.S. Support Care Cancer. 2008;16:791–801.

    Google Scholar 

  3. Cella D, Davis K, Breitbart W, Curt G. Fatigue coalition cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19:3385–91.

    Google Scholar 

  4. NCCN (National Comprehensive Cancer Network). Clinical practice guidelines in oncology: cancer-related fatigue. V.1.2021. National Comprehensive Cancer Network, Inc; 2020. Accessed 28 June 2021.

    Google Scholar 

  5. Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007;16:787–95.

    Google Scholar 

  6. World Health Organization. ICD-11 International statistical classification of diseases and related health problems, 11th revision. Geneva: World Health Organization; 2019.

    Google Scholar 

  7. Noakes TD. Fatigue is a brain-derived emotion that regulates the exercise behavior to ensure the protection of whole body homeostasis. Front Physiol. 2012;3:82. https://doi.org/10.3389/fphys.2012.00082. Epub 2012 Apr 11.

    CrossRef  Google Scholar 

  8. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med. 2001;134(9 Pt 2):838–43.

    Google Scholar 

  9. Scott JA, Lasch KE, Barsevick AM, Piault-Louis E. Patients’ experiences with cancer-related fatigue: a review and synthesis of qualitative research. Oncol Nurs Forum. 2011;38(3):E191–203.

    Google Scholar 

  10. Smith SK, Herndon JE, Lyerly HK, Coan A, Wheeler JL, Staley T, Abernethy AP. Correlates of quality of life-related outcomes in breast cancer patients participating in the pathfinders pilot study. Psychooncology. 2011;20(5):559–64.

    Google Scholar 

  11. Ahlberg K, Ekman T, Gaston-Johansson F. Fatigue, psychological distress, coping resources, and functional status during radiotherapy for uterine cancer. Oncol Nurs Forum. 2005;32:633–40.

    Google Scholar 

  12. Oktay JS, Bellin MH, Scarvalone S, Appling S, Helzlsouer KJ. Managing the impact of posttreatment fatigue on the family: breast cancer survivors share their experiences. Fam Syst Health. 2011;29(2):127–37.

    Google Scholar 

  13. Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.

    Google Scholar 

  14. Tiedtke C, de Rijk A, Dierckx de Casterle B, Christiaens MR, Donceel P. Experiences and concerns about ‘returning to work’ for women breast cancer survivors: a literature review. Psychooncology. 2010;19:677–83.

    Google Scholar 

  15. Bruera E. Cancer-related fatigue: a multidimensional syndrome. J Support Oncol. 2010;8:175–6.

    Google Scholar 

  16. Bower JE. Cancer-related fatigue--mechanisms, risk factors, and treatment. Nat Rev Clin Oncol. 2014;11:597–609.

    Google Scholar 

  17. Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32:1840–50. https://doi.org/10.1200/JCO.2013.53.4495.

    CrossRef  Google Scholar 

  18. Kenne Sarenmalm E, Browall M, Gaston-Johansson F. Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer. J Pain Symptom Manage. 2014;47(4):731–41. https://doi.org/10.1016/j.jpainsymman.2013.05.012.

    CrossRef  Google Scholar 

  19. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care. 2001;10:245–55.

    Google Scholar 

  20. Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012;9(7):414–26.

    Google Scholar 

  21. Wood LJ, Weymann K. Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster. Curr Opin Support Palliat Care. 2013;7:54–9.

    Google Scholar 

  22. Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun. 2007;21:413–27.

    Google Scholar 

  23. Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun. 2012;26(6):830–48. https://doi.org/10.1016/j.bbi.2012.05.004.

    CrossRef  Google Scholar 

  24. Brode S, Cooke A. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Crit Rev Immunol. 2008;28:109–26.

    Google Scholar 

  25. Elsea CR, Roberts DA, Wood LJ, et al. Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS One. 2008;3:e2355.

    Google Scholar 

  26. Hei TK, Zhou H, Chai Y, et al. Radiation induced non-targeted response:mechanism and potential clinical implications. Curr Mol Pharmacol. 2011;4:96–105.

    Google Scholar 

  27. Mahoney SE, Davis JM, Murphy EA, et al. Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1. Brain Behav Immun. 2013;27:155–61.

    Google Scholar 

  28. Wang XS, Williams LA, Krishnan S, et al. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012;26:699–705.

    Google Scholar 

  29. Brown LF, Kroenke K. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics. 2009;50(5):440–7. https://doi.org/10.1176/appi.psy.50.5.440.

    CrossRef  Google Scholar 

  30. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12(suppl 1):22–34.

    Google Scholar 

  31. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11):2919–25.

    Google Scholar 

  32. Donovan KA, McGinty HL, Jacobsen PB. A systematic review of research using the diagnostic criteria for cancer-related fatigue. Psychooncology. 2013;22:737–44.

    Google Scholar 

  33. Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P. The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice? Breast. 2017;34:44–52. https://doi.org/10.1016/j.breast.2017.04.012. Epub 2017 May 11. PMID: 28500901.

    CrossRef  Google Scholar 

  34. Karthikeyan G, Jumnani D, Prabhu R, et al. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care. 2012;18(3):165–75.

    Google Scholar 

  35. Wang XS, Zhao F, Fisch MJ, et al. Prevalence and characteristics of moderate-to-severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–32. https://doi.org/10.1002/cncr.28434.

    CrossRef  Google Scholar 

  36. Bevilacqua LA, Dulak D, Schofield E, et al. Prevalence and predictors of depression, pain, and fatigue in older- versus younger-adult cancer survivors. Psycho-Oncology. 2018;27:900–7. https://doi.org/10.1002/pon.4605.

    CrossRef  Google Scholar 

  37. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38:27–43.

    Google Scholar 

  38. Gielissen MF, Schattenberg AV, Verhagen CA, et al. Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant. 2007;39:595–603.

    Google Scholar 

  39. Naidoo J, Page DB, Li PT, et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol. 2015;26(12):2375–91. https://doi.org/10.1093/annonc/mdv383.

    CrossRef  Google Scholar 

  40. Linendoll N, Saunders T, Burns R, Nyce JD, Wendell KB, Evens AM, Parsons SK. Health-related quality of life in Hodgkin lymphoma: a systematic review. Health Qual Life Outcomes. 2016;14(1):114. https://doi.org/10.1186/s12955-016-0515-6. PMID: 27473596; PMCID: PMC4966803.

    CrossRef  Google Scholar 

  41. Heutte N, Flechtner HH, Mounier N, Mellink WA, Meerwaldt JH, Eghbali H, et al. Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol. 2009;10:1160–70. https://doi.org/10.1016/S1470-2045(09)70258-X.

    CrossRef  Google Scholar 

  42. Sekse RJT, Hufthammer KO, Vika ME. Fatigue and quality of life in women treated for various types of gynaecological cancers: a cross-sectional study. J Clin Nurs. 2015;24:546–55.

    Google Scholar 

  43. Harrington CB, Hansen JA, Moskowitz M. It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med. 2010;40(2):163–81.

    Google Scholar 

  44. Wang XS, Woodruff JF. Cancer-related and treatment-related fatigue. Gynecol Oncol. 2015;136(3):446–52.

    Google Scholar 

  45. Arriba LN, Fader AN, Frasure HE, von Gruenigen VE. A review of issues surrounding quality of life among women with ovarian cancer. Gynecol Oncol. 2010;119(2):390–6.

    Google Scholar 

  46. Prue G, Allen J, Gracey J, Rankin J, Cramp F. Fatigue in gynecological cancer patients during and after anticancer treatment. J Pain Symptom Manage. 2010;39(2):197–210.

    Google Scholar 

  47. Williams AL, Heckler CE, Paterson CL, et al. Cancer-related fatigue in breast cancer survivors: a longitudinal analysis compared to matched controls. J Clin Oncol. 2017;35(15):10045. https://doi.org/10.1200/JCO.2017.35.15_suppl.10045.

    CrossRef  Google Scholar 

  48. Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27(6):965–74. https://doi.org/10.1093/annonc/mdw099. Epub 2016.

    CrossRef  Google Scholar 

  49. Busson R, van der Kaaij M, Mounier N, Aleman BMP, et al. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes. 2019;17(1):115. https://doi.org/10.1186/s12955-019-1186-x. PMID: 31266501; PMCID: PMC6604328.

    CrossRef  Google Scholar 

  50. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag. 2007;34(1):94–104.

    Google Scholar 

  51. Olson K, Krawchuk A, Quddusi T. Fatigue in individuals with advanced cancer in active treatment and palliative settings. Cancer Nurs. 2007;30:E1–10.

    Google Scholar 

  52. Fabi A, Bhargava B, Fatigoni S, Jordan K, Ripamonti CI, et al. on behalf of the ESMO Guidelines Committee. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol. 2020;31(6):713–23. https://doi.org/10.1016/j.annonc.2020.02.016.

    CrossRef  Google Scholar 

  53. Howell D, Keshavarz H, Broadfield L, et al. A pan Canadian practice guideline for screening, assessment, and management of cancer-related fatigue in adults version 2, 2015. Toronto: Canadian Association of Psychosocial Oncology; 2015. https://www.capo.ca/guidelines. Accessed 28 Nov 2020.

    Google Scholar 

  54. Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manag. 2008;35(1):20–30. https://doi.org/10.1016/j.jpainsymman.2007.02.040.

    CrossRef  Google Scholar 

  55. Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009;20:17–25.

    Google Scholar 

  56. Löwe B, Kroenke K, Herzog W, Gräfe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81:61–6.

    Google Scholar 

  57. Fisher MI, Davies C, Lacy H, et al. Oncology Section EDGE Task Force on cancer: measures of cancer-related fatigue – a systematic review. Rehabil Oncol. 2018;36:93–105.

    Google Scholar 

  58. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 2019;34(3 Suppl 2):13–9.

    Google Scholar 

  59. Mendoza TR, Wang XS, Kugaya A, et al. The rapid assessment of fatigue severity in cancer patients; use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186–96.

    Google Scholar 

  60. Weis J, Tomaszewski KA, Hammerlid E, et al. International psychometric validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12). J Natl Cancer Inst. 2017;109(5):273. Available at https://doi.org/10.1093/jnci/djw273. Accessed 13 Feb 2020.

    Google Scholar 

  61. Weis J, Wirtz MA, Tomaszewski KA, et al. EORTC Quality of Life Group. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): results from the international psychometric validation. Psychooncology. 2019;28(8):1753–61.

    Google Scholar 

  62. Mock V, Frangakis C, Davidson NE, et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology. 2005;14:464–77.

    Google Scholar 

  63. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;(2):CD006145.

    Google Scholar 

  64. Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial. Int J Cancer. 2015;137(2):471–80. https://doi.org/10.1002/ijc.29383.

    CrossRef  Google Scholar 

  65. Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med. 2012;43:1–24.

    Google Scholar 

  66. Brown JC, Huedo-Medina TB, et al. Efficacy of exercise intervention in modulating cancer-related fatigue among adult cancer survivors: a meta analysis. Cancer Epidemiol Biomark Prev. 2011;20:123–33.

    Google Scholar 

  67. Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;15(8):CD007566.

    Google Scholar 

  68. Mustian K, Morrow G, Carroll J, et al. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007;12:52–67.

    Google Scholar 

  69. Barsevick AM, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100:1302–10.

    Google Scholar 

  70. Williams SA, Schreier AM. The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer. Appl Nurs Res. 2005;18:138–47.

    Google Scholar 

  71. Reif K, de Vries U, Petermann F, Görres S. A patient education program is effective in reducing cancer-related fatigue: a multi-centre randomised two-group waiting-list controlled intervention trial. Eur J Oncol Nurs. 2013;17(2):204–13. https://doi.org/10.1016/j.ejon.2012.07.002.

    CrossRef  Google Scholar 

  72. Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2005;23:6027–36.

    Google Scholar 

  73. Stanton AL, Ganz PA, Kwan L, et al. Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol. 2005;23:6009–18.

    Google Scholar 

  74. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009(1):CD006953.

    Google Scholar 

  75. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004;22:507–16.

    Google Scholar 

  76. Corbett TK, Groarke A, Devane D, Carr E, Walsh JC, McGuire BE. The effectiveness of psychological interventions for fatigue in cancer survivors: systematic review of randomised controlled trials. BMJ. 2019;8:324. https://doi.org/10.1186/s13643-019-1230-2.

    CrossRef  Google Scholar 

  77. Poort H, Peters M, Bleijenberg G, Gielissen MFM, Goedendorp MM, Jacobsen P, Verhagen S, Knoop H. Psychosocial interventions for fatigue during cancer treatment with palliative intent. Cochrane Database Syst Rev. 2017;7(7):CD012030. https://doi.org/10.1002/14651858.CD012030.pub2.

    CrossRef  Google Scholar 

  78. Spahrkäs SS, Looijmans A, Sanderman R, et al. Beating cancer-related fatigue with the Untire mobile app: results from a waiting-list randomized controlled trial. Psychooncology. 2020;29(11):1823–34. https://doi.org/10.1002/pon.5492.

    CrossRef  Google Scholar 

  79. Carlson LE, Bultz BD. Mind-body interventions in oncology. Curr Treat Options in Oncol. 2008;9:127–34.

    Google Scholar 

  80. Ledesma D, Kumano H. Mindfulness-based stress reduction and cancer: a meta-analysis. Psychooncology. 2009;18:571–9.

    Google Scholar 

  81. Shennan C, Payne S, Fenlon D. What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psychooncology. 2011;20:681–97.

    Google Scholar 

  82. Greenlee H, Balneaves LG, Carlson LE, et al. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr. 2014;50:346–58.

    Google Scholar 

  83. Danhauer SC, Addington EL, Cohen L, et al. Yoga for symptom management in oncology: a review of the evidence base and future directions for research. Cancer. 2019;125(12):1979–89.

    Google Scholar 

  84. Cramer H, Lauche R, Klose P, et al. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev. 2017;3:1.

    Google Scholar 

  85. Bruera E, Yennurajalingam S, Palmer JL, et al. Methylphenidate and/or nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol. 2013;31:2421–7.

    Google Scholar 

  86. Roth AJ, Nelson C, Rosenfeld B, et al. Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer. 2010;116:5102–10.

    Google Scholar 

  87. Lasheen W, Walsh D, Mahmoud F, et al. Methylphenidate side effects in advanced cancer: a retrospective analysis. Am J Hosp Palliat Care. 2010;27(1):16–23. Epub 2009 Sept 10.

    Google Scholar 

  88. Escalante CP, Meyers C, Reuben JM, et al. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014;20:8–14.

    Google Scholar 

  89. Spathis A, Fife K, Blackhall F, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32:1882–8.

    Google Scholar 

  90. Hovey E, de Souza P, Marx G, et al. Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer. 2014;22:1233–42.

    Google Scholar 

  91. Peuckmann-Post V, Elsner F, Krumm N, Trottenberg R, Radbruch L. Pharmacological treatments for fatigue associated with palliative care (Review). Cochrane Database Syst Rev. The Cochrane Library. 2010;(11):CD006788.

    Google Scholar 

  92. Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;1:961–8.

    Google Scholar 

  93. Weis J, Horneber M. Definition and prevalence of cancer-related fatigue. In: Cancer-related fatigue. London: Springer; 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Peer-Support Research, Faculty of Medicine, University of Freiburg, University Medical Center, Comprehensive Cancer Center, Freiburg, Germany

    Joachim Weis

Authors
  1. Joachim Weis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim Weis .

Editor information

Editors and Affiliations

  1. Department of Applied Health Research, University College London, London, UK

    Angelos P. Kassianos

Rights and permissions

Reprints and Permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Weis, J. (2022). Quality of Life and Cancer-Related Fatigue: Prevalence, Assessment and Interventions. In: Kassianos, A.P. (eds) Handbook of Quality of Life in Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-84702-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84702-9_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84701-2

  • Online ISBN: 978-3-030-84702-9

  • eBook Packages: MedicineMedicine (R0)